Join
Live feed
·
INSIDERFilingvia Quantisnow
Vera Therapeutics Inc. logo

PRESIDENT AND CEO Fordyce Marshall sold $710,578 worth of shares (16,925 units at $41.98), decreasing direct ownership by 6% to 257,163 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VERA (Vera Therapeutics Inc.) and more on Quantisnow.